RGLS : Summary for Regulus Therapeutics Inc. - Yahoo Finance

U.S. Markets closed

Regulus Therapeutics Inc. (RGLS)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.35-0.10 (-4.08%)
At close: 4:00PM EST

2.45 0.10 (4.26%)
After hours: 4:56PM EST

People also watch
PTCTPTLACEMPTGTXOMED
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.45
Open2.50
Bid2.00 x 1300
Ask3.50 x 200
Day's Range2.35 - 2.50
52 Week Range2.13 - 8.90
Volume529,597
Avg. Volume574,306
Market Cap124.37M
Beta2.30
PE Ratio (TTM)-1.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube29 days ago

    ETFs with exposure to Regulus Therapeutics, Inc. : December 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Regulus Therapeutics, Inc. Here are 5 ETFs with the largest exposure to RGLS-US. Comparing the performance and risk of Regulus Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
    Insider Monkeylast month

    How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers

    Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap […]

  • Investopedialast month

    Regulus Expands Liver and Kidney Drug Pipeline

    Regulus added two new clinical drug candidates to treat liver and kidney diseases.